Prognosis and Risk Factors of Gastric Cancer in Patients With Intestinal Metaplasia

Study ID
NCT02325323

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

GASTRIMED

Trial Summary

This prospective cohort study aims to assess the incidence of gastric cancer in patients with intestinal metaplasia in body of stomach or angular incisure. As secondary objectives, among the patients included in the cohort, the study will: assess the incidence of low grade dysplasia, assess the incidence of high grade dysplasia in patients with low grade dysplasia, identify risk factors of progression to dysplasia and gastric cancer.

More informations

Trial Starting Date

May 31,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

2000